Syncope resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Line 42: | Line 42: | ||
{{familytree/end}} | {{familytree/end}} | ||
===Diagnostic Flowchart in Patients with Suspected Syncope=== | ===Diagnostic and Treatment Flowchart in Patients with Suspected Syncope=== | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | | | | | | {{familytree | | | | | | A01 | | | | | | | | A01= <div style="float: left; text-align: left; width: 30em; padding:1em;">'''Characterize symptoms'''<br> | ||
{{familytree | | | | | | | | :❑ ask for activity before incident | ||
{{familytree | | | | | | | :❑ ask for position before incident ([[supine]], sitting, standing) | ||
{{familytree | | |,|-|-|-| | :❑ ask for precipitating factors (stress, exercise, warm environment) | ||
{{familytree | | | :❑ look for prodrome ([[diaphoresis]], [[nausea]], [[blurry vision]]) | ||
:❑ inquire about duration (< 5 sec , > 5 sec) | |||
:❑ ask for medication intake (vasodilators, diuretics) </div> }} | |||
{{familytree | | | | | | |!| | | | | | | | }} | |||
{{familytree | | | | | | Z01 | | | | | | | | Z01= <div style="float: left; text-align: left; width: 30em; padding:1em;">'''Examine the patient:'''<br> | |||
{{familytree | | | | | | | | | | |! | :❑supine and standing BP measurement | ||
{{familytree | | | | | | | | :❑ [[hearth rate]] and breathing | ||
:❑ [[cardiac auscultation]] | |||
{{familytree | | | | | | |! | :❑ examine for neurological symptoms <br> | ||
{{familytree | | | | | | | '''Order [[EKG]]''' </div> }} | ||
{{familytree | | |,|-|-|-|+|-|-|-|.| | | | | }} | |||
{{familytree | | B01 | | B02 | | B03 | | | B01= <div style="float: left; text-align: left; width: 20em; padding:1em;"> ❑ Absence of heart disease <br> ❑ History of recurrent syncope <br> ❑ After unpleasant sight or smell <br> ❑ Associated to nausea <br> ❑ Head rotation or pressure to carotid sinsus </div> |B02=<div style="float: left; text-align: left; width: 30em; padding:1em;"> ❑ After standing up or prolonged standing <br> ❑ Start of new vasodepresive drug <br> ❑ Presence of autonomic neuropathy <br> ❑ Fall in systolic BP ≥ 20 mmHg and/or in diastolic BP of at least≥ 10 mmHg between the supine and sitting BP reading.</div>|B03=<div style="float: left; text-align: left; width: 25em; padding:1em;"> ❑ Presence of structural hearth disease <br> ❑ During exertion <br> ❑ Palpitations prior to [[LOC]] <br> ❑ '''Abnormal EKG findings:''' | |||
:❑ Bifascicular block, [[Wide QRS]](≥ 0.12 s) | |||
:❑ [[Second degree AV block classification|Mobitz I second degree AV block]] | |||
:❑ Non-sustained VT , Early repolarization | |||
:❑ Pre-excited QRS complexes | |||
:❑ Long or short QT intervals | |||
:❑ Q waves ([[myocardial infarction]])</div>}} | |||
{{familytree | | |!| | | |!| | | |!| }} | |||
{{familytree | | C01 | | C02 | | C03 | | | C01= <div style="float: left; text-align: center; width: 20em; padding:1em;">'''Reflex''' </div>|C02= '''[[Orthostatic hypotension]]''' |C03= <div style="float: left; text-align: center; width: 25em; padding:1em;"> '''Cardiovascular''' </div> }} | |||
{{familytree | | |!| | | |!| | | |!| | | }} | |||
{{familytree | | D01 | | D02 | | D03 | | | D01= <div style="float: left; text-align: left;"> '''Treatment''' <br> ❑ Explain diagnosis, provide reassurance <br> ❑ Explain risk of recurrence and avoidance of triggers <br> ❑ Isometric PCM in patients with [[prodrome]] </div>| D02= <div style="float: left; text-align: left;"> '''Treatment''' <br> ❑ Adequate hydration and salt intake <br> ❑ [[midodrine]] or [[fludrocortisone]] as adjunctive therapy if needed </div> | D03=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Treatment''' (depends on the cause of the arrhythmia): | |||
:❑ [[Cardiac pacing]]: for [[sinus node disease]], [[Second degree AV block classification|Mobitz II AV block]], [[BBB]] with positive EPS | |||
:❑ [[Catheter ablation]]: for [[SVT]] and [[VT]] in absence of structural hearth disease | |||
:❑ [[Antiarrhythmic drug]] therapy: for [[AF]], failed catheter ablation | |||
:❑ Implantable cardioverter defibrillator: VT with [[heart disease]], EPS induced [[VT]] in patients with previous [[MI]], [[VT]] and [[inherited cardiomyopathy]] </div>}} | |||
{{familytree/end}} | {{familytree/end}} | ||
Algorithms based in 2009 ESC Guidelines for the Diagnosis and Management of Syncope. <ref name="pmid19713422">{{cite journal| author=Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA). Heart Failure Association (HFA). Heart Rhythm Society (HRS). Moya A et al.| title=Guidelines for the diagnosis and management of syncope (version 2009). | journal=Eur Heart J | year= 2009 | volume= 30 | issue= 21 | pages= 2631-71 | pmid=19713422 | doi=10.1093/eurheartj/ehp298 | pmc=PMC3295536 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19713422 }} </ref> | |||
===Treatment of Syncope=== | ===Treatment of Syncope=== |
Revision as of 20:52, 28 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]
Definition
Syncope is defined as a transient loss of consciousness due to cerebral hypoperfusion, characterized by a rapid onset, a short duration and a spontaneous complete recovery.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Management
Syncope in the Context of Transient LOC
Determine if there was LOC | |||||||||||||||||||||||||||||||||||
Yes: ❑ It had a rapid onset? ❑ It was of short duration? ❑ Did the patient had a spontaneous complete recovery? | No: | ||||||||||||||||||||||||||||||||||
No to ≥ 1: (exclude the following before proceeding with syncope evaluation) ❑ Coma ❑ Aborted SCD ❑ Epilepsy
❑ Metabolic disorders:
❑ Vertebrobasilar TIA | Yes: ❑ Transient LOC | ||||||||||||||||||||||||||||||||||
Non traumatic | Traumatic | ||||||||||||||||||||||||||||||||||
Syncope | Seizure | Psychogenic | |||||||||||||||||||||||||||||||||
Diagnostic and Treatment Flowchart in Patients with Suspected Syncope
Characterize symptoms
| |||||||||||||||||||||||||||||||
Examine the patient:
| |||||||||||||||||||||||||||||||
❑ Absence of heart disease ❑ History of recurrent syncope ❑ After unpleasant sight or smell ❑ Associated to nausea ❑ Head rotation or pressure to carotid sinsus | ❑ After standing up or prolonged standing ❑ Start of new vasodepresive drug ❑ Presence of autonomic neuropathy ❑ Fall in systolic BP ≥ 20 mmHg and/or in diastolic BP of at least≥ 10 mmHg between the supine and sitting BP reading. | ❑ Presence of structural hearth disease ❑ During exertion ❑ Palpitations prior to LOC ❑ Abnormal EKG findings:
| |||||||||||||||||||||||||||||
Reflex | Orthostatic hypotension | Cardiovascular | |||||||||||||||||||||||||||||
Treatment ❑ Explain diagnosis, provide reassurance ❑ Explain risk of recurrence and avoidance of triggers ❑ Isometric PCM in patients with prodrome | Treatment ❑ Adequate hydration and salt intake ❑ midodrine or fludrocortisone as adjunctive therapy if needed | Treatment (depends on the cause of the arrhythmia):
| |||||||||||||||||||||||||||||
Algorithms based in 2009 ESC Guidelines for the Diagnosis and Management of Syncope. [3]
Treatment of Syncope
Reflex and orthostatic intolerance | Cardiac | Unexplained and high risk SCD | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Unpredictable or high- frequency | Predictable or low frequency | Cardiac arrythmias SCD | Structural (cardiac or pulmonary) | i.e. CAD, HOCM, ARV, channelopathies | |||||||||||||||||||||||||||||||||||||||||||||||||||
Consider specific therapy or delayed treatment based by ECG documentation | Education, reassurance, avoidance of triggers | Specfic therapy of the culprit arrythmia | Treatment of underlying disease | Consider ICD therapy | |||||||||||||||||||||||||||||||||||||||||||||||||||
Algorithms based in 2009 ESC Guidelines for the Diagnosis and Management of Syncope. [3]
Do's
- Tilt testing is indicated when it is of clinical value to demonstrate susceptibility to reflex syncope to the patient.
- Tilt testing should be considered to discriminate between reflex and OH syncope.
- Perform tilt testing if psychiatric disease.
- Tilt testing may be considered for differentiating syncope with jerking movements from epilepsy.
- If syncope happened after standing up position, there should be documentation with active standing or tilt testing in order to diagnose OH.
- Perform CSM if patient >40 years with syncope of unknown aetiology after initial evaluation.
- If multiple unexplained falls; perform tilt testing.
- Consider ILR before embarking on cardiac pacing in patients with suspected or certain reflex syncope presenting with frequent or traumatic syncopal episodes.
- Evaluate neurologically if syncope is due to ANF, to evaluate underlying disease.
Don'ts
- Don't perform carotid sinus massage (CSM) in patients with previous TIA or stroke within the past 3 months and in patients with carotid sinus bruits (except if carotid sinus Doppler studies excluded significant stenosis.
- Don't use tilt testing for assessment of treatment.
- Don't perform isoproterenol tilt testing in patients with ischaemic heart disease.
- Don't use ATP test as a diagnostic test to select patients for cardiac pacing, owing to lack of correlation with spontaneous syncope,.
- Don't perform EPS if there is already indication for ICD in patients with ischemic heart with suspected arrhythmic cause.
- Don't perform EPS in patients with normal ECK, no heart disease, and no palpitations.
References
- ↑ Khoo, C.; Chakrabarti, S.; Arbour, L.; Krahn, AD. (2013). "Recognizing life-threatening causes of syncope". Cardiol Clin. 31 (1): 51–66. doi:10.1016/j.ccl.2012.10.005. PMID 23217687. Unknown parameter
|month=
ignored (help) - ↑ Kapoor, WN. (2000). "Syncope". N Engl J Med. 343 (25): 1856–62. doi:10.1056/NEJM200012213432507. PMID 11117979. Unknown parameter
|month=
ignored (help) - ↑ 3.0 3.1 Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA). Heart Failure Association (HFA). Heart Rhythm Society (HRS). Moya A; et al. (2009). "Guidelines for the diagnosis and management of syncope (version 2009)". Eur Heart J. 30 (21): 2631–71. doi:10.1093/eurheartj/ehp298. PMC 3295536. PMID 19713422 Check
|pmid=
value (help).